Dry Needling on the Treatment of Chronic Somatosensory Tinnitus: An Open Pilot Study
Unknown statusNot applicableNCT03295890
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Self paring study, double blind placebo controlled with chronic tinnitus patients attended at the Tinnitus Research Group HC- FMUSP, complaining of neck and/or cervical pain and with myofascial trigger point in the head, neck and/or shoulder. They were submitted to a complete otolaryngologist evaluation which included history, physical examination and myofascial trigger point checkup. Patients also performed blood tests, tonal and vocal audiometry, and psychoacoustic tinnitus measures. Self paring study, double blind placebo controlled. Each patient will be subjected to the dry needling placebo, 4 sessions, 1 per week, with placebo stretching, followed by washout period of two weeks, and 4 more dry needling therapeutic sessions and active stretching. On the first day of the study will be conducted the following evaluation: questionnaires THI and NDI, quantification of cervical pain and tinnitus through the Visual analogue scale (VAS), search and confirmation of the presence of PGM and cervical pain, psychoacoustic measures and somatic tests. This evaluation will be repeated at the end of the four placebo sessions, at the beginning of therapeutic needling sessions and at the end of the same.
Study details
- Official title
- Dry Needling on the Treatment of Chronic Somatosensory Tinnitus: An Open Pilot Study
- Conditions
- Tinnitus
- Trigger Point Pain, Myofascial
- Somatosensory Disorders
- Interventions
- Procedure: Dry Needing
- Sponsor
- University of Sao Paulo General Hospital
- Start date
- 2016-07-29
- Primary completion
- 2018-06-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * With constant tinnitus, unilateral or bilateral, for more than 6 months, * Both sexes, * Over 18 years, * Presence of at least one PGM (active or latent), * Diagnosis of Myofascial pain syndrome, according to the criteria of Travell and Simons. Exclusion Criteria: * With prior experience with the use of needles for therapeutic purposes, * With formal contraindication to dry needling, as chronic use of anticoagulants or hematologic diseases, * Those who refuse the proposed therapies, for example, phobia of needles, * In use of medications for pain able to interfere with the result of the study, such as anti-inflammatory and or muscle relaxers, until 30 days before the initial assessment,
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03295890